LS
PVCT

Lupo Securities’s PROVECTUS BIOPHARMACEUTICALS, INC. (DE) PVCT Stock Holding History

Lupo Securities’s Portfolio PVCT Stock Details PVCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$2K Buy
3,700
+600
+19% +$307 0.02% 106
2015
Q2 		$2K Buy
3,100
+2,300
+288% +$1.88K 0.01% 98
2015
Q1 		$1K Hold
800
– – ﹤0.01% 451
2014
Q4 		$640 Buy
+800
New +$731 ﹤0.01% 533

Other funds holding PVCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CCB
Cutter & Co Brokerage Ballwin, Missouri $423M AUM 15.02% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

Lupo Securities's PVCT Position: Q3 2015 in Review

Lupo Securities increased its PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) stake by 19% in Q3 2015, buying an estimated $307 and bringing the position to 3,700 shares worth $2K. The position accounts for 0.02% of the portfolio, ranked #106.

Lupo Securities first reported a position in PVCT in Q4 2014 and has held it in 4 quarters since. 39 funds tracked by Wall St. Rank hold PVCT as of Q3 2015.

  • Lupo Securities held 3,700 shares of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) worth $2K as of Q3 2015.
  • Lupo Securities bought 600 PROVECTUS BIOPHARMACEUTICALS, INC. (DE) shares in Q3 2015, an estimated $307.
  • PROVECTUS BIOPHARMACEUTICALS, INC. (DE) made up 0.02% of Lupo Securities's portfolio in Q3 2015, its #106 holding.
  • Lupo Securities first reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in Q4 2014 and has held it in 4 quarters since.
  • 39 funds tracked by Wall St. Rank held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) as of Q3 2015.

Based on Lupo Securities's 13F filing for Q3 2015, filed 13 Nov 2015.